Single answer
Is Autolus Therapeutics plc (AUTL) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Autolus Therapeutics plc is $8.87, which is $7.16 (419.14%) above the current price today's price.
Low target: $7.60 | High target: $11.00
Company snapshot
A quick overview of the business and its public profile.
Autolus Therapeutics plc a clinicalstage biopharmaceutical company develops T cell therapies for the treatment of cancer The companys clinicalstage programs include obecabtagene autoleucel AUTO1 a CD19targeting programmed T cell investigational therapy that is in Phase 1b2 clinical trial for the treatment of adult ALL AUTO122 which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL AUTO4 a programmed T cell investigational therapy for the treatment of peripheral Tcell lymphoma targeting TRBC1 AUTO6NG a programmed T cell investigational therapy which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma and AUTO8 a product candidate that is in a Phase I clinical trial for multiple myeloma It also focuses on developing AUTO5 a hematological product candidate which is in preclinical development The company was incorporated in 2014 and is headquartered in London the United Kingdom
Website: https://www.autolus.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.10. Cash flow to debt ratio: -3.86. Net profit margin: -439.68%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Autolus Therapeutics plc is $4.1M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Autolus Therapeutics plc 10 years ago, but if you had invested on 2018-06-22 when the price was $25.00, you would have made a loss of $23.24 per share or 92.96%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.